These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4795755)

  • 21. Topical corticosteroid response in clinically normal eyes of Negroes forty years and older.
    Deutsch A; Hiatt RL; Risser CF
    Ann Ophthalmol; 1971 Jun; 3(6):604-6. PubMed ID: 5164433
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers.
    Holland EJ; Bartlett JD; Paterno MR; Usner DW; Comstock TL
    Cornea; 2008 Jan; 27(1):50-5. PubMed ID: 18245967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute ocular tolerance of corticosteroidal solutions.
    Schlagel CA; Hagans JA; Soda JA; Lamb DJ
    J Clin Pharmacol J New Drugs; 1968; 8(4):245-53. PubMed ID: 4873483
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological validation of a feline model of steroid-induced ocular hypertension.
    Bhattacherjee P; Paterson CA; Spellman JM; Graff G; Yanni JM
    Arch Ophthalmol; 1999 Mar; 117(3):361-4. PubMed ID: 10088814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of prednisolone eye drops. A trial of the effects of prednisolone phosphate eye drops on the intra-ocular pressure of normal volunteers.
    Ramsell TG; Trillwood W; Draper G
    Br J Ophthalmol; 1967 Jun; 51(6):398-402. PubMed ID: 5338280
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic factors related to glaucoma.
    Armaly MF
    Ann N Y Acad Sci; 1968 Jul; 151(2):861-75. PubMed ID: 5263693
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of dexamethasone acetate as a topical ophthalmic formulation.
    Leibowitz HM; Kupferman A; Stewart RH; Kimbrough RL
    Am J Ophthalmol; 1978 Sep; 86(3):418-23. PubMed ID: 717508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids.
    Leibowitz HM; Bartlett JD; Rich R; McQuirter H; Stewart R; Assil K
    Arch Ophthalmol; 1996 Aug; 114(8):933-7. PubMed ID: 8694727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the effects of 0.1% bromfenac sodium eye drops and corticosteroids after small incision lenticule extraction].
    Jiang Y; Li Y; Jin YM; Zhang JY
    Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):18-22. PubMed ID: 28162195
    [No Abstract]   [Full Text] [Related]  

  • 30. Corticosteroid therapy of eye disease. Fifty years later.
    Raizman M
    Arch Ophthalmol; 1996 Aug; 114(8):1000-1. PubMed ID: 8694704
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical diclofenac versus dexamethasone after strabismus surgery: a double-blind randomized clinical trial of anti-inflammatory effect and ocular hypertensive response.
    Khan HA; Amitava AK
    Indian J Ophthalmol; 2007; 55(4):271-5. PubMed ID: 17595475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticosteroid-induced uveitis.
    Martins JC; Wilensky JT; Asseff CF; Obstbaum SA; Buerk KM
    Am J Ophthalmol; 1974 Apr; 77(4):433-7. PubMed ID: 4819444
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma.
    Lorenz K; Wasielica-Poslednik J; Bell K; Renieri G; Keicher A; Ruckes C; Pfeiffer N; Thieme H
    PLoS One; 2017; 12(2):e0171636. PubMed ID: 28199397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ocular hemodynamics following local administration of clonidine].
    Marquardt R; Pillunat LE; Stodtmeister R
    Klin Monbl Augenheilkd; 1988 Dec; 193(6):637-41. PubMed ID: 3065571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uveitis in association with topically administered corticosteroid.
    Krupin T; LeBlanc RP; Becker B; Kolker AE; Podos SM
    Am J Ophthalmol; 1970 Dec; 70(6):883-5. PubMed ID: 5490616
    [No Abstract]   [Full Text] [Related]  

  • 36. The reproducibility of the intraocular pressure response to dexamethasone.
    Palmberg PF; Mandell A; Wilensky JT; Podos SM; Becker B
    Am J Ophthalmol; 1975 Nov; 80(5):844-56. PubMed ID: 1190278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5 beta-Dihydrocortisol: possible mediator of the ocular hypertension in glaucoma.
    Southren AL; Gordon GG; l'Hommedieu D; Ravikumar S; Dunn MW; Weinstein BI
    Invest Ophthalmol Vis Sci; 1985 Mar; 26(3):393-5. PubMed ID: 3972522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of ozurdex on intraocular pressure. A real life clinical practice study].
    Jiménez-Gómez B; González-Montpetit M; Fonollosa Calduch A; Orive Bañuelos A; Valsero Franco S
    Arch Soc Esp Oftalmol; 2015 Sep; 90(9):421-5. PubMed ID: 25817950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Response to corticosteroid in asthenopic patients].
    Kageyama M; Nakagawa Y
    Nippon Ganka Gakkai Zasshi; 1970 Jul; 74(7):630-8. PubMed ID: 5465871
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of intravitreal injection of dexamethasone 0.7 mg (Ozurdex®) on intraocular pressure in patients with macular edema.
    Mazzarella S; Mateo C; Freixes S; Burés-Jelstrup A; Rios J; Navarro R; García-Arumí J; Corcóstegui B; Arrondo E
    Ophthalmic Res; 2015; 54(3):143-9. PubMed ID: 26394206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.